Abstract:Background: The demonstrated role of mitogen-activated protein kinase (MAPK) in both cell apoptosis and the inflammation pathway makes it an attractive target for photoreceptor protection. The aim of this study was to investigate the protective effects of MAPK antagonists against photoreceptor degeneration and retinal inflammation in a rat model of light-induced retinal degeneration. Methods: Sprague Dawley rats were treated with intravitreal injections of MAPK antagonists, inhibitors of p-P38, phosphorylated-extracellular regulated kinase (p-ERK) 1/2, and p-c-Jun N-terminal kinase (JNK) just before they were assigned to dark adaptation. After dark adaptation for 24 h, rats were exposed to blue light (2500 lux) in a light box for 24 h, and then returned to the normal 12-h light/12-h dark cycle. Samples were collected at different time points. MAPK expression during light exposure was examined with immunofluorescence. Photoreceptor death was detected with histopathology and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The expression of retinal p-ERK1/2, caspase 3, activated caspase 3, tumor necrosis factor (TNF)-alpha, and interleukin (IL)-1 beta was examined by Western blotting. Differences between groups were evaluated using unpaired one-way analysis of variance and least significant difference post hoc tests. Results: MAPKs (P38, ERK1/2, and p-JNK) were phosphorylated and activated in the light injury groups, compared with normal group, and their expressions were mainly elevated in the outer nuclear layer (ONL). Among the selected MAPK antagonists, only the p-ERK1/2 inhibitor attenuated the loss of photoreceptors and the thinning of ONL in light injury groups. Besides, p-ERK1/2 inhibitor refrained light-induced photoreceptor apoptosis, which was presented by TUNEL positive cells. Light injury significantly increased the expression of p-ERK1/2 (1.12 +/- 0.06 vs. 0.57 +/- 0.08, t = 9.99, P < 0.05; 1.23 +/- 0.03 vs. 0.57 +/- 0.08, t = 11.90, P < 0.05; and 1.12 +/- 0.12 vs. 0.57 +/- 0.08, t = 9.86, P < 0.05; F = 49.55, P < 0.001), and induced caspase 3 activating (0.63 +/- 0.06 vs. 0.14 +/- 0.05, t = 13.67, P < 0.05; 0.74 +/- 0.05 vs. 0.14 +/- 0.05, t = 16.87, P < 0.05; and 0.80 +/- 0.05 vs. 0.14 +/- 0.05, t = 18.57, P < 0.05; F = 100.15, P < 0.001), compared with normal group. The p-ERK1/2 inhibitor significantly reduced p-ERK1/2 overexpression (0.61 +/- 0.06 vs. 1.12 +/- 0.06, t = -9.26, P < 0.05; 0.77 +/- 0.06 vs. 1.23 +/- 0.03, t = -8.29, P < 0.05; and 0.68 +/- 0.03 vs. 1.12 +/- 0.12, t = -7.83, P < 0.05; F = 49.55, P < 0.001) and downregulated caspase 3 activating (0.23 +/- 0.04 vs. 0.63 +/- 0.06, t = -11.24, P < 0.05; 0.43 +/- 0.03 vs. 0.74 +/- 0.05, t = -8.86, P < 0.05; and 0.58 +/- 0.03 vs. 0.80 +/- 0.05, t = -6.17, P < 0.05; F = 100.15, P < 0.001), compared with light injury group. No significant change in the total level of caspase 3 was seen in different groups (F = 0.56, P = 0.75). As for inflammation, light injury significantly increased the expression of TNF-alpha (0.42 +/- 0.04 vs. 0.25 +/- 0.05, t = 5.99, P < 0.05; 0.65 +/- 0.03 vs. 0.25 +/- 0.05, t = 14.87, P < 0.05; and 0.86 +/- 0.04 vs. 0.25 +/- 0.05, t = 22.58, P < 0.05; F = 160.27, P < 0.001) and IL-1 beta (0.24 +/- 0.01 vs. 0.19 +/- 0.02, t = 2.33, P < 0.05; 0.35 +/- 0.02 vs. 0.19 +/- 0.02, t = 7.97, P < 0.05; and 0.48 +/- 0.04 vs. 0.19 +/- 0.02, t = 14.69, P < 0.05; F = 77.29, P < 0.001), compared with normal group. P-ERK1/2 inhibitor significantly decreased the overexpression of TNF-alpha (0.22 +/- 0.02 vs. 0.42 +/- 0.04, t = -7.40, P < 0.05; 0.27 +/- 0.02 vs. 0.65 +/- 0.03, t = -14.27, P < 0.05; and 0.33 +/- 0.03 vs. 0.86 +/- 0.04, t = -19.58, P < 0.05; F = 160.27, P < 0.001) and IL-1 beta (0.13 +/- 0.03 vs. 0.24 +/- 0.01, t = -5.77, P < 0.05; 0.17 +/- 0.01 vs. 0.22 +/- 0.02, t = -9.18, P < 0.05; and 0.76 +/- 0.05 vs. 0.48 +/- 0.04, t = -13.12, P < 0.05; F = 77.29, P < 0.001), compared with light injury group. Conclusion: The p-ERK1/2 inhibitor might protect the retina from light-induced photoreceptor degeneration and retinal inflammation.

The relationship between MERTK gene and protein kinase C in the phagocytic process of human retinal pigment epithelial cells

The role of receptor protein tyrosine kinase MERTK and intracellular Ca2+ playing in the phagocytosis of human retinal pigment epithelial cells

[The Alteration of Cyclic Adenosine Monophosphate and Protein Kinase C in the Phagocytic Process of Human Pigment Epithelial Cells].

Mertk gene expression and photoreceptor outer segment phagocytosis by cultured rat bone marrow mesenchymal stem cells

Inhibiting the Activation of MAPK (ERK1/2) in Stressed Müller Cells Prevents Photoreceptor Degeneration

The Protective Effect of EGF-activated ROS in Human Corneal Epithelial Cells by Inducing Mitochondrial Autophagy Via Activation TRPM2.

Changes of Protein Kinase C for the Proliferation of Retinal Pigment Epithelium Cells Induced by Subretinal Fluid

KRT8 Phosphorylation Regulates the Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells Through Autophagy Modulation

Cleavage of Mer tyrosine kinase (MerTK) from the cell surface contributes to the regulation of retinal phagocytosis

The alteration of MERTK gene in different passage of retinal pigment epithelium cells

MERTK-Dependent Ensheathment of Photoreceptor Outer Segments by Human Pluripotent Stem Cell-Derived Retinal Pigment Epithelium

Microglia Inhibition Delays Retinal Degeneration Due to MerTK Phagocytosis Receptor Deficiency

Inflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in Mertk-associated retinitis pigmentosa

Retinal atrophy, inflammation, phagocytic and metabolic disruptions develop in the MerTK-cleavage-resistant mouse model

Chaperonin-Containing TCP1 Subunit 5 Protects Against the Effect of Mer Receptor Tyrosine Kinase Knockdown in Retinal Pigment Epithelial Cells by Interacting With Filamentous Actin and Activating the LIM-Kinase 1/Cofilin Pathway

Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing

Protein tyrosine phosphatase 1B regulates the activity of retinal pigment epithelial cells.

Effect of Phosphorylated-Extracellular Regulated Kinase 1/2 Inhibitor on Retina from Light-induced Photoreceptor Degeneration

Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.

MERTK Inhibitor Associated Retinal Toxicity in a Human

[Epigallocatechin Gallate Attenuates the Expression of Regulated Upon Activation Normal T Cell Expressed and Secreted Induced by Lipopolysaccharide in Human Retinal Endothelial Cells].